Published on: July 10, 2020 at 09:30PM
Condition: Diabetes Mellitus, Type 2
Interventions: Drug: JTT-662; Drug: Placebo
Sponsor: Akros Pharma Inc.
Recruiting
https://ift.tt/2O9VDBR
Friday, 10 July 2020
New diabetes clinical trial: Study to Evaluate Safety, Tolerability, Pharmacokinetics & Pharmacodynamics of JTT-662 in Subjects With Type 2 Diabetes
Subscribe to:
Post Comments (Atom)
No comments:
Post a Comment
Nothing happens without a Reason
Make Something out of it.